English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#primarysclerosingcholangitis search results

VoiceofRita's profile picture. We're all just walking eachother home.
Tenacious B
 @VoiceofRita
Sep 29, 2020

#donatelife #primarysclerosingcholangitis Un-silent killer. I am an #ambassador Please donate your organs. Many of us can't afford more. #thankyou

VoiceofRita's tweet image. #donatelife #primarysclerosingcholangitis Un-silent killer. I am an #ambassador Please donate your organs. Many of us can't afford more. #thankyou
1
2
12
0
0
VoiceofRita's profile picture. We're all just walking eachother home.
Tenacious B
 @VoiceofRita
May 19, 2020

This is @SarahLi54884462 I have PSC too and it's one of the reasons I'm sharing this off of Facebook. Sarah is dying and needs a living donor. Sarah is my friend. Please she's looking for a hero. She needs a liver. #primarysclerosingcholangitis

VoiceofRita's tweet image. This is @SarahLi54884462 I have PSC too and it's one of the reasons I'm sharing this off of Facebook. Sarah is dying and needs a living donor. Sarah is my friend. Please she's looking for a hero. She needs a liver. #primarysclerosingcholangitis
VoiceofRita's tweet image. This is @SarahLi54884462 I have PSC too and it's one of the reasons I'm sharing this off of Facebook. Sarah is dying and needs a living donor. Sarah is my friend. Please she's looking for a hero. She needs a liver. #primarysclerosingcholangitis
5
7
13
0
0
LizzieAbyMD's profile picture. Transplant Hepatology @UMN_GIHEP| @LiverFellow co-founder | AASLD Emerging Liver Scholar alum| Former UCLA Chief Resident |@pomonacollege alum|Tweets=own
Lizzie Aby, MD
 @LizzieAbyMD
Oct 13, 2024

Living with primary sclerosing cholangitis (#PSC)? Earn $500 after completing the #Microbiota Transplant Therapy Research Study! Contact research coordinator: Lulu Chen at [email protected] if interested! #PrimarySclerosingCholangitis #FMT

LizzieAbyMD's tweet image. Living with primary sclerosing cholangitis (#PSC)? Earn $500 after completing the #Microbiota Transplant Therapy Research Study! Contact research coordinator: Lulu Chen at chen8124@umn.edu if interested! #PrimarySclerosingCholangitis #FMT
0
4
25
4
3K
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Feb 28, 2018

Over the last decade, Mayo Clinic has amassed likely the largest and most comprehensive sample registry from patients with #PrimarySclerosingCholangitis. These invaluable specimens will help Mayo researchers with their goal. mayocl.in/2CoMeT8 #RareDiseaseDay

MayoClinic's tweet image. Over the last decade, Mayo Clinic has amassed likely the largest and most comprehensive sample registry from patients with #PrimarySclerosingCholangitis. These invaluable specimens will help Mayo researchers with their goal. mayocl.in/2CoMeT8 #RareDiseaseDay
1
14
34
0
0
PSCSupportUK's profile picture. Patient organisation for primary sclerosing cholangitis. Info and support for patients | the PSC App | research towards a cure. #LetsBeatPSC #LetsBeatPSC
PSC Support
 @PSCSupportUK
Oct 29, 2022

Today is Global PSC Awareness Day. The whole global PSC community is working together to find effective treatments for PSC as soon as possible. #PSCDay #RareLiverDiseases #PrimarySclerosingCholangitis #LetsBeatPSC #Hope @EuropeLiver

PSCSupportUK's tweet image. Today is Global PSC Awareness Day. The whole global PSC community is working together to find effective treatments for PSC as soon as possible. #PSCDay #RareLiverDiseases #PrimarySclerosingCholangitis #LetsBeatPSC #Hope @EuropeLiver
0
26
53
0
0
heppharm's profile picture. British Hepatology Pharmacy Group. Affiliate group of BASL for pharmacists and pharmacy technicians aiming to develop knowledge/understanding of liver disorders
BHPG
 @heppharm
Oct 29, 2022

A brilliant summary to raise awareness of #Primarysclerosingcholangitis management. ‘The 6 C’s of PSC’ #PSCAwarenessDay2022

heppharm's tweet image. A brilliant summary to raise awareness of #Primarysclerosingcholangitis management. ‘The 6 C’s of PSC’ #PSCAwarenessDay2022
0
1
8
0
0
PSCSupportUK's profile picture. Patient organisation for primary sclerosing cholangitis. Info and support for patients | the PSC App | research towards a cure. #LetsBeatPSC #LetsBeatPSC
PSC Support
 @PSCSupportUK
Nov 26, 2021

👏This is the best 2-minute explanation of PSC strictures! It is an extract from our recent Ask the Expert session on bile duct regeneration with @FSampaziotis. #PSCFacts #LetsBeatPSC #PrimarySclerosingCholangitis

0
7
22
2
0
GileadSciences's profile picture. At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. Read more: https://t.co/TZWHS6iRTe
Gilead Sciences
 @GileadSciences
Nov 10, 2018

Learn more about #primarysclerosingcholangitis (PSC), a chronic condition that affects bile ducts in the liver. Lindsey shares her story here: bit.ly/2PvvIH8. #LiverMtg18

0
4
11
0
0
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Apr 19, 2021

#PrimarySclerosingCholangitis is a disease of the bile ducts. Learn more about the signs, symptoms and treatment options: mayocl.in/3gi9gOD?

MayoClinic's tweet image. #PrimarySclerosingCholangitis is a disease of the bile ducts. Learn more about the signs, symptoms and treatment options: mayocl.in/3gi9gOD?
0
8
39
5
0
JHEP_Reports's profile picture. JHEP Reports publishes manuscripts concerned with basic, translational and clinical research in the field of hepatology - IF: 7.5
JHEP Reports
 @JHEP_Reports
Dec 3

🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis

JHEP_Reports's tweet image. 🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis
0
25
61
30
5K
DrFalkUK's profile picture. Passionate about supporting education & awareness for patients & health care professionals in the areas of IBD & liver disease
DR FALK
 @DrFalkUK
Mar 3, 2022

TOMORROW: Working in #AILD? Still time to reg for our all day virtual/in person (RCGPs London) Falk Forum ‘Controversies in #PSC’ Top experts discussing latest in diagnosing & managing this complex disease #primarysclerosingcholangitis Reg FalkPlus App ow.ly/53Uo50I9s2p

DrFalkUK's tweet image. TOMORROW: Working in #AILD? Still time to reg for our all day virtual/in person (RCGPs London) Falk Forum ‘Controversies in #PSC’ Top experts discussing latest in diagnosing & managing this complex disease #primarysclerosingcholangitis Reg FalkPlus App ow.ly/53Uo50I9s2p
DrFalkUK's tweet image. TOMORROW: Working in #AILD? Still time to reg for our all day virtual/in person (RCGPs London) Falk Forum ‘Controversies in #PSC’ Top experts discussing latest in diagnosing & managing this complex disease #primarysclerosingcholangitis Reg FalkPlus App ow.ly/53Uo50I9s2p
0
3
7
0
0
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Oct 9, 2018

Mayo Clinic researchers use #ArtificialIntelligence, clinical data to create prediction tool for #PrimarySclerosingCholangitis. mayocl.in/2QECVSe

MayoClinic's tweet image. Mayo Clinic researchers use #ArtificialIntelligence, clinical data to create prediction tool for #PrimarySclerosingCholangitis. mayocl.in/2QECVSe
0
19
7
0
0
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Feb 3, 2019

“We may have #PrimarySclerosingCholangitis (PSC), but PSC doesn’t have us.” With PSC, inflammation causes scars within the bile ducts. PSC Partners Seeking a Cure CEO Ricky Safer shares their mission with Dr. Lazaridis on #MayoClinicConnect. mayocl.in/2sTX6Si

MayoClinic's tweet image. “We may have #PrimarySclerosingCholangitis (PSC), but PSC doesn’t have us.” With PSC, inflammation causes scars within the bile ducts. PSC Partners Seeking a Cure CEO Ricky Safer shares their mission with Dr. Lazaridis on #MayoClinicConnect. mayocl.in/2sTX6Si
0
4
8
0
0
PSCSupportUK's profile picture. Patient organisation for primary sclerosing cholangitis. Info and support for patients | the PSC App | research towards a cure. #LetsBeatPSC #LetsBeatPSC
PSC Support
 @PSCSupportUK
Jan 16, 2023

Just diagnosed? Ten tips on handling your diagnosis from people living with PSC 🙌 pscsupport.org.uk/just-diagnosed/ #PSC #PrimarySclerosingCholangitis

PSCSupportUK's tweet image. Just diagnosed? Ten tips on handling your diagnosis from people living with PSC 🙌 pscsupport.org.uk/just-diagnosed/ #PSC #PrimarySclerosingCholangitis
0
2
3
0
452
MedComm_MC's profile picture. MedComm is a peer‐reviewed, online OA journal that publishes the pioneer works of medicine on the basis of novelty, timeliness and significance on human health.
MedComm
 @MedComm_MC
Oct 22

#Article in @MedComm_MC Disruption of Bile Acid Metabolism in the Gut–Liver Axis Predisposes Mice to Inflammatory Bowel Disease👉doi.org/10.1002/mco2.7… #PrimarySclerosingCholangitis #PSC #BileAcid #GutLiverAxis #ImmuneCell #homeostasis #IBD

MedComm_MC's tweet image. #Article in @MedComm_MC Disruption of Bile Acid Metabolism in the Gut–Liver Axis Predisposes Mice to Inflammatory Bowel Disease👉doi.org/10.1002/mco2.7… #PrimarySclerosingCholangitis #PSC #BileAcid #GutLiverAxis #ImmuneCell #homeostasis #IBD
0
0
0
0
11
BritishPanel's profile picture. The British Research Panel is a community of patient volunteers. We aim to promote the research and development of new medicine for a variety of illnesses.
British Research Panel
 @BritishPanel
Oct 16

ARE YOU LIVING WITH PSC? 🫂 We are looking for people living with #PSC (#PrimarySclerosingCholangitis) to participate in an online interview, to generate more knowledge about what it is like to live with PSC. Fill in the following questionnaire👇 britishresearchpanel.co.uk/psc-survey/

BritishPanel's tweet image. ARE YOU LIVING WITH PSC? 🫂 We are looking for people living with #PSC (#PrimarySclerosingCholangitis) to participate in an online interview, to generate more knowledge about what it is like to live with PSC. Fill in the following questionnaire👇 britishresearchpanel.co.uk/psc-survey/
0
0
0
1
85
DrKcoldwell's profile picture. @DaphneJacksonTr Fellow at the @KIROxford Researching the gut and liver in PSC. https://t.co/COncfb9Jie
Kate Coldwell
 @DrKcoldwell
Sep 30

Thanks VUmc, Amsterdam hosting #PSC meeting. New experience to attend a small highly-specialised meeting. We are rare people who work on a rare disease! So much interest in DYNAMHIX in PSC and the gut-liver axis. #microbiome #primarysclerosingcholangitis #LetsBeatPSC

0
0
0
0
14
Gastroent_MDPI's profile picture. Gastroenterology Insights (ISSN 2036-7422) is an international open access journal published by MDPI. Editor-in-Chief: Dr. Joseph D. Feuerstein
Gastroenterology Insights MDPI
 @Gastroent_MDPI
Aug 25

🆕 "Ileal Bile Acid Transporter Inhibitors for Adult Patients with Autoimmune Cholestatic Liver Diseases: A Systematic Review and Meta-Analysis" Full text: mdpi.com/2036-7422/16/3… #PrimaryBiliaryCholangitis #PrimarySclerosingCholangitis #CholestaticPruritus #LiverDisease

0
0
0
0
31
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Aug 21

#PrimarySclerosingCholangitis is a #RareLiverDisease that scars bile ducts & raises the risk of #BileDuctCancer. Often diagnosed late, it’s among the most aggressive cancers. We’re working to address PSC’s core pathophysiology & improve outcomes. More here:mayocl.in/3RI5oXW

RectifyPharma's tweet image. #PrimarySclerosingCholangitis is a #RareLiverDisease that scars bile ducts & raises the risk of #BileDuctCancer. Often diagnosed late, it’s among the most aggressive cancers. We’re working to address PSC’s core pathophysiology & improve outcomes. More here:mayocl.in/3RI5oXW
0
0
0
0
12
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
May 23

#DYK Healthy bile flow and composition are key to #BiliaryHealth—supporting digestion, waste removal, and protecting the liver. Disruptions, especially in bile salts and phospholipids, are central to diseases like #PrimarySclerosingCholangitis. Learn more: bit.ly/3V5Vul7

0
0
0
0
31
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
May 9

At #EASLCongress 2025 we’re presenting data that demonstrates the potential for a B4/BSEP PFM to address the core pathology of multiple liver & biliary diseases, incl. #PrimarySclerosingCholangitis. Read more: bit.ly/4m8O2lP

RectifyPharma's tweet image. At #EASLCongress 2025 we’re presenting data that demonstrates the potential for a B4/BSEP PFM to address the core pathology of multiple liver & biliary diseases, incl. #PrimarySclerosingCholangitis. Read more: bit.ly/4m8O2lP
1
1
2
0
202
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Apr 23

Dr. Eric Bell will present on our lead program #PrimarySclerosingCholangitis at #EASLCongress 2025 during the Immune-mediated & Cholestatic Diseases session. We look forward to engaging with experts & sharing insights on advancing treatments. Read more: bit.ly/3Go6eHS

RectifyPharma's tweet image. Dr. Eric Bell will present on our lead program #PrimarySclerosingCholangitis at #EASLCongress 2025 during the Immune-mediated & Cholestatic Diseases session. We look forward to engaging with experts & sharing insights on advancing treatments. Read more: bit.ly/3Go6eHS
0
0
0
0
35
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Apr 7

Proud to see our work featured in Communications Biology! The study provides structural insights into mutation-driven BSEP misfolding & dysfunction, advancing our development of #PFMs for #PrimarySclerosingCholangitis, PFIC2 & related conditions. More here:bit.ly/42yoo29

RectifyPharma's tweet image. Proud to see our work featured in Communications Biology! The study provides structural insights into mutation-driven BSEP misfolding & dysfunction, advancing our development of #PFMs for #PrimarySclerosingCholangitis, PFIC2 & related conditions. More here:bit.ly/42yoo29
0
0
0
0
45
DrFalkUK's profile picture. Passionate about supporting education & awareness for patients & health care professionals in the areas of IBD & liver disease
DR FALK
 @DrFalkUK
Mar 28

TODAY: We welcome all delegates to Falk Forum 101 ‘Liver Life: Navigating #AIH & Beyond’ @RCGPs London and look forward to stimulating & enlightening discussions on the complexities of #autoimmunehepatitis with updates on the management of #primarysclerosingcholangitis

DrFalkUK's tweet image. TODAY: We welcome all delegates to Falk Forum 101 ‘Liver Life: Navigating #AIH & Beyond’ @RCGPs London and look forward to stimulating & enlightening discussions on the complexities of #autoimmunehepatitis with updates on the management of #primarysclerosingcholangitis
0
1
1
0
121
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Feb 28

#Rare doesn't mean alone! This #RareDiseaseDay, we stand with the #PrimarySclerosingCholangitis (PSC) community and advocates such as PSC Partners Seeking a Cure, who work tirelessly to create a better future for those living with #PSC. More here: bit.ly/3QvGkUe

5
0
0
0
59
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Jan 27

2025 will be an exciting year for Rectify! We’re advancing our lead program to the clinic for #PrimarySclerosingCholangitis (PSC) and our novel treatment for #cardiorenalmetabolic. Follow us as we push innovation to improve patient outcomes. Learn more: bit.ly/408DwTh

RectifyPharma's tweet image. 2025 will be an exciting year for Rectify! We’re advancing our lead program to the clinic for #PrimarySclerosingCholangitis (PSC) and our novel treatment for #cardiorenalmetabolic. Follow us as we push innovation to improve patient outcomes. Learn more: bit.ly/408DwTh
0
1
4
0
68
yourkirstyness's profile picture. ~ Book lover ~ Am Dram Performer ~ Not a natural redhead ~ Living with IBD and PSC
𝓚𝓲𝓻𝓼𝓽𝔂 (𝖘𝖍𝖊/𝖍𝖊𝖗)
 @yourkirstyness
Jan 9

Looking for a podcast to listen to? Check out my interview with Crohns and Autism Awareness Advocate! I waffle about my IBD journey (and I do mean waffle) and then we have a blether about Dr Who! open.spotify.com/episode/6djg55… #crohns #colitis #PrimarySclerosingCholangitis

0
1
3
0
81
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Dec 23

As 2024 comes to a close, we're reflecting on our tremendous progress - lead candidate for #PrimarySclerosingCholangitis, in vivo POC data for #CardioRenalMetabolic and ex vivo POC for #Neuro. Thanks to our team & partners for their work and dedication!

0
2
1
0
85
mhenrique028's profile picture. @ufrj Interest in liver/GI, physics, soccer and music. Learner
Matheus Souza
 @mhenrique028
Dec 22

Very happy to see our work published in @AGA_CGH!! These data may help future evidence-based surveillance strategies for hepatobiliary malignancies in #PrimarySclerosingCholangitis #PSC. doi.org/10.1016/j.cgh.… #MedTwitter #LiverTwitter #GITwitter

mhenrique028's tweet image. Very happy to see our work published in @AGA_CGH!! These data may help future evidence-based surveillance strategies for hepatobiliary malignancies in #PrimarySclerosingCholangitis #PSC. doi.org/10.1016/j.cgh.… #MedTwitter #LiverTwitter #GITwitter
1
0
4
0
356
JHEP_Reports's profile picture. JHEP Reports publishes manuscripts concerned with basic, translational and clinical research in the field of hepatology - IF: 7.5
JHEP Reports
 @JHEP_Reports
Dec 3

🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis

JHEP_Reports's tweet image. 🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis
0
25
61
30
5K
RectifyPharma's profile picture. Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function and address the underlying cause of serious diseases.
Rectify Pharma
 @RectifyPharma
Nov 27

Thanks to all who joined our virtual R&D Event! We look forward to sharing more as we advance RTY-694, an ABCB4/BSEP dual targeted #PFM that uniquely addresses the core pathophysiology of #PrimarySclerosingCholangitis, towards the clinic. More: bit.ly/3V5Vul7

RectifyPharma's tweet image. Thanks to all who joined our virtual R&D Event! We look forward to sharing more as we advance RTY-694, an ABCB4/BSEP dual targeted #PFM that uniquely addresses the core pathophysiology of #PrimarySclerosingCholangitis, towards the clinic. More: bit.ly/3V5Vul7
0
0
0
0
124
LizzieAbyMD's profile picture. Transplant Hepatology @UMN_GIHEP| @LiverFellow co-founder | AASLD Emerging Liver Scholar alum| Former UCLA Chief Resident |@pomonacollege alum|Tweets=own
Lizzie Aby, MD
 @LizzieAbyMD
Oct 13, 2024

Living with primary sclerosing cholangitis (#PSC)? Earn $500 after completing the #Microbiota Transplant Therapy Research Study! Contact research coordinator: Lulu Chen at [email protected] if interested! #PrimarySclerosingCholangitis #FMT

LizzieAbyMD's tweet image. Living with primary sclerosing cholangitis (#PSC)? Earn $500 after completing the #Microbiota Transplant Therapy Research Study! Contact research coordinator: Lulu Chen at chen8124@umn.edu if interested! #PrimarySclerosingCholangitis #FMT
0
4
25
4
3K
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Apr 19, 2021

#PrimarySclerosingCholangitis is a disease of the bile ducts. Learn more about the signs, symptoms and treatment options: mayocl.in/3gi9gOD?

MayoClinic's tweet image. #PrimarySclerosingCholangitis is a disease of the bile ducts. Learn more about the signs, symptoms and treatment options: mayocl.in/3gi9gOD?
0
8
39
5
0
JHepatology's profile picture. Official journal of @EASLnews Geneva/Switzerland - RT ≠ endorsement - IF: 33.0 #hepatology #medicine #liver #healthcare #liverdisease
Journal of Hepatology
 @JHepatology
Mar 12, 2023

🆕EXPERT OPINION❕ #PrimarySclerosingCholangitis and overlap features of autoimmune hepatitis A coming of age or an age-ist problem❓ 🔓#OpenAccess at👉bit.ly/3T4eAXn @amandaricciuto @CholestasisDoc #LiverTwitter

JHepatology's tweet image. 🆕EXPERT OPINION❕ #PrimarySclerosingCholangitis and overlap features of autoimmune hepatitis A coming of age or an age-ist problem❓ 🔓#OpenAccess at👉bit.ly/3T4eAXn @amandaricciuto @CholestasisDoc #LiverTwitter
0
16
38
11
8K
PSCSupportUK's profile picture. Patient organisation for primary sclerosing cholangitis. Info and support for patients | the PSC App | research towards a cure. #LetsBeatPSC #LetsBeatPSC
PSC Support
 @PSCSupportUK
Oct 29, 2022

Today is Global PSC Awareness Day. The whole global PSC community is working together to find effective treatments for PSC as soon as possible. #PSCDay #RareLiverDiseases #PrimarySclerosingCholangitis #LetsBeatPSC #Hope @EuropeLiver

PSCSupportUK's tweet image. Today is Global PSC Awareness Day. The whole global PSC community is working together to find effective treatments for PSC as soon as possible. #PSCDay #RareLiverDiseases #PrimarySclerosingCholangitis #LetsBeatPSC #Hope @EuropeLiver
0
26
53
0
0
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Feb 28, 2018

Over the last decade, Mayo Clinic has amassed likely the largest and most comprehensive sample registry from patients with #PrimarySclerosingCholangitis. These invaluable specimens will help Mayo researchers with their goal. mayocl.in/2CoMeT8 #RareDiseaseDay

MayoClinic's tweet image. Over the last decade, Mayo Clinic has amassed likely the largest and most comprehensive sample registry from patients with #PrimarySclerosingCholangitis. These invaluable specimens will help Mayo researchers with their goal. mayocl.in/2CoMeT8 #RareDiseaseDay
1
14
34
0
0
AJPathology's profile picture. The official journal of the American Society for Investigative Pathology @ASIPath, examining discoveries in basic and translational pathobiology
The American Journal of Pathology
 @AJPathology
Apr 4, 2022

Bile from Patients with #PrimarySclerosingCholangitis Contains Mucosal-Associated Invariant T Cell Antigens. From authors @Oslounivsykehus, @UniOslo, and @karolinskainst. FREE to all readers: ajp.amjpathol.org/article/S0002-… #liverdisease

AJPathology's tweet image. Bile from Patients with #PrimarySclerosingCholangitis Contains Mucosal-Associated Invariant T Cell Antigens. From authors @Oslounivsykehus, @UniOslo, and @karolinskainst. FREE to all readers: ajp.amjpathol.org/article/S0002-… #liverdisease
0
3
9
1
0
JHepatology's profile picture. Official journal of @EASLnews Geneva/Switzerland - RT ≠ endorsement - IF: 33.0 #hepatology #medicine #liver #healthcare #liverdisease
Journal of Hepatology
 @JHepatology
Oct 17, 2023

🆕Article in press❕ Cyclosporine vs. tacrolimus after #livertransplantation for #primarysclerosingcholangitis – a propensity-score matched intention-to-treat analysis 🔓#OpenAccess at👉bit.ly/3ZU3MOR @Dr_ABERGFredrik #LiverTwitter

JHepatology's tweet image. 🆕Article in press❕ Cyclosporine vs. tacrolimus after #livertransplantation for #primarysclerosingcholangitis – a propensity-score matched intention-to-treat analysis 🔓#OpenAccess at👉bit.ly/3ZU3MOR @Dr_ABERGFredrik #LiverTwitter
0
7
16
2
3K
MayoClinic's profile picture. An integrated clinical practice, education and research institution specializing in treating patients. Account maintained by @MayoClinic.
Mayo Clinic
@MayoClinic
Oct 9, 2018

Mayo Clinic researchers use #ArtificialIntelligence, clinical data to create prediction tool for #PrimarySclerosingCholangitis. mayocl.in/2QECVSe

MayoClinic's tweet image. Mayo Clinic researchers use #ArtificialIntelligence, clinical data to create prediction tool for #PrimarySclerosingCholangitis. mayocl.in/2QECVSe
0
19
7
0
0
JHEP_Reports's profile picture. JHEP Reports publishes manuscripts concerned with basic, translational and clinical research in the field of hepatology - IF: 7.5
JHEP Reports
 @JHEP_Reports
Dec 3

🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis

JHEP_Reports's tweet image. 🟪NEW Article in press❕ Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Epidemiology, Mortality, and Impact of Diagnostic Sequence 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #PrimarySclerosingCholangitis
0
25
61
30
5K
VoiceofRita's profile picture. We're all just walking eachother home.
Tenacious B
 @VoiceofRita
Sep 29, 2020

#donatelife #primarysclerosingcholangitis Un-silent killer. I am an #ambassador Please donate your organs. Many of us can't afford more. #thankyou

VoiceofRita's tweet image. #donatelife #primarysclerosingcholangitis Un-silent killer. I am an #ambassador Please donate your organs. Many of us can't afford more. #thankyou
1
2
12
0
0
VoiceofRita's profile picture. We're all just walking eachother home.
Tenacious B
 @VoiceofRita
Feb 29, 2020

#donatelife #primarysclerosingcholangitis Yes this is one of the things that has made my life very hard. I'm an advocate.

VoiceofRita's tweet image. #donatelife #primarysclerosingcholangitis Yes this is one of the things that has made my life very hard. I'm an advocate.
1
1
2
0
0
PSCSupportUK's profile picture. Patient organisation for primary sclerosing cholangitis. Info and support for patients | the PSC App | research towards a cure. #LetsBeatPSC #LetsBeatPSC
PSC Support
 @PSCSupportUK
Oct 29, 2019

✅Today is world PSC Awareness Day 2019 - how much do you know about #PSC? This year, we are testing YOUR knowledge by asking you to take our PSC quiz to help raise awareness of #PrimarySclerosingCholangitis. Thank you! buff.ly/2qTWf6v #PSCAware #LetsBeatPSC

PSCSupportUK's tweet image. ✅Today is world PSC Awareness Day 2019 - how much do you know about #PSC? This year, we are testing YOUR knowledge by asking you to take our PSC quiz to help raise awareness of #PrimarySclerosingCholangitis. Thank you! buff.ly/2qTWf6v #PSCAware #LetsBeatPSC
2
25
34
0
0

Something went wrong.


Something went wrong.


United States Trends